Suicide risk identification and mitigation in patients with chronic pain prescribed opioid medication
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Managing suicide risk in chronic pain patients is difficult. Strategies like opioid safety, frequent appointments, and non-opioid treatments can reduce suicide risk for these individuals.
Area Of Science
- Pain Management
- Psychiatry
- Public Health
Background
- Chronic pain significantly increases suicide risk.
- Clinical guidelines for managing suicidality in chronic pain are lacking.
- Effective suicide risk mitigation strategies are crucial for this population.
Purpose Of The Study
- To explore treatment strategies for managing suicidality in patients with chronic pain.
- To provide a framework for clinical decision-making in suicide risk mitigation for this demographic.
- To highlight the importance of a multidisciplinary approach to chronic pain and suicidality.
Main Methods
- Case study analysis of three patients with chronic pain and suicidality.
- Review of current risk mitigation strategies applicable to chronic pain patients.
- Discussion of pharmacotherapy and non-pharmacological interventions.
Main Results
- Implementing strategies such as opioid education, naloxone distribution, and lethal means safety can decrease suicide risk.
- Individualized opioid tapers and consideration of nonopioid pharmacotherapy are important.
- Addressing modifiable risk factors and increasing appointment frequency are key components of management.
Conclusions
- A comprehensive treatment plan incorporating various strategies is essential for managing suicidality in chronic pain.
- Proactive risk mitigation is vital for improving outcomes in patients with co-occurring chronic pain and suicidal ideation.
- Further research and guideline development are needed to support clinicians.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...